Your browser doesn't support javascript.
loading
Actinomycotic Osteomyelitis of the Maxilla in a Patient on Phenytoin.
Aghahosseini, Farzaneh; Ghasemzadeh Hoseini, Elaheh; Mahdavi, Nazanin.
Afiliação
  • Aghahosseini F; Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghasemzadeh Hoseini E; Department of Oral and Maxillofacial Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahdavi N; Department of Oral & Maxillofacial Medicine, School of Dentistry, Kashan University of Medical Sciences, Kashan, Iran.
Front Dent ; 19: 3, 2022.
Article em En | MEDLINE | ID: mdl-35937152
Actinomycosis is caused by Actinomyces species and is relatively rare in humans. Because of the special collateral blood flow, osteomyelitis is less common in the maxilla than the mandible. Although there are few case reports for jaw osteomyelitis, actinomycotic osteomyelitis associated with phenytoin therapy has not been reported before. The data show that antiepileptic drugs induce suppression of the immune system. This report presents a rare case of a 58-year-old man on phenytoin with actinomycotic osteomyelitis, and reviews the relevant literature.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Dent Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Dent Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã